Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...
This study presents valuable findings for identifying biotypes of depression patients using white matter measures, which are under-utilised and under-appreciated in current biological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results